重新利用现有药物治疗创伤后应激障碍
Olha Strilbytska1, Oleh Lushchak1,2,3
1Department of Biochemistry and Biotechnology, Vasyl Stefanyk Carpathian National University, 57 Shevchenko Str., Ivano-Frankivsk, 76018, Ukraine.
Chronic stress (Thousand Oaks, Calif.)
|October 30, 2025
概括
药物再利用为开发创伤后应激障碍 (PTSD) 新疗法提供了一个有希望的策略. 这种方法利用已知安全性配置文件的现有药物来加速PTSD治疗的开发.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 神经科学是一个神经科学.
背景情况:
- 创伤后应激障碍 (PTSD) 是一个日益增长的全球心理健康问题.
- 目前的PTSD治疗面临挑战,原因是疾病的复杂性和有限的治疗选择.
研究的目的:
- 探索药物重用作为加速PTSD治疗发展的战略.
- 总结现有的重用药物,并讨论创新型创伤后应激障碍候选者的潜力.
主要方法:
- 文献综述和关于用于PTSD的药物重用研究的摘要.
- 讨论潜在用于PTSD治疗的特定药物类别,包括α-上腺素调节剂,大麻素,谷氨酸调节剂和抗精神病药物.
主要成果:
- 药物重定向识别了已确立的安全性和疗效的化合物,用于新的适用.
- 几种药物类别显示出减轻PTSD症状的潜力,为临床试验提供了更快的途径.
结论:
- 药物再利用提供了一个可行的和有效的战略,以加快开发有效的PTSD疗法.
- 需要进一步调查潜在的缺点,并全面讨论负面方面.
更多相关视频
相关概念视频
Post-traumatic Stress Disorder
469
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
469
Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791
Drug Therapy
237
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
237
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Antidepressant Drugs: Overview
1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Psychosis: Goals of Pharmacotherapy
457
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
457


